Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines

Shannon L Nowotarski1, David J Feith2, Lisa M Shantz3

  • 1Department of Biochemistry, The Pennsylvania State University Berks College, Reading, PA, USA.

Cancer Growth and Metastasis
|September 19, 2015
PubMed

Insights

Nonmelanoma skin cancer (NMSC) incidence is rising. Polyamines are essential for tumor growth, and targeting their metabolism shows promise for NMSC treatment in high-risk individuals.

Area of Science:

  • Dermatology and Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Nonmelanoma skin cancer (NMSC) is a significant global health issue, with increasing incidence in immunosuppressed individuals and those on photosensitizing drugs.
  • Understanding the molecular mechanisms driving NMSC is crucial for developing effective therapeutic strategies.
  • Polyamines, essential for cell growth, are implicated in NMSC development and maintenance.

Purpose of the Study:

  • To review mouse models used to investigate the role of polyamines in NMSC.
  • To summarize findings on polyamine metabolism in NMSC development.
  • To highlight the therapeutic potential of targeting polyamine pathways.

Main Methods:

  • Review of existing literature on NMSC mouse models.
  • Analysis of studies investigating polyamine metabolism in skin cancer.
  • Examination of data from clinical trials on polyamine inhibitors.

Main Results:

  • Elevated polyamines are critical for NMSC tumor growth.
  • Dysregulation of polyamine biosynthetic and catabolic enzymes is observed in NMSC.
  • Genetic alterations in epidermal polyamines in mice highlight their role in tumor promotion and cell survival.

Conclusions:

  • Polyamines play a key role in NMSC development and progression.
  • Pharmacological inhibition of polyamine metabolism is a promising therapeutic strategy for NMSC, particularly in high-risk populations.